4D Molecular Therapeutics Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:4D Molecular Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8010860
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月20日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
4D Molecular Therapeutics Inc (4D Molecular Therapeutics) focuses on the discovery and development of targeted and proprietary AAV gene therapy vectors and therapeutic products. The company developed a discovery platform, Directed Vector Evolution, which empowers to create customized gene delivery vehicles (novel AAV vectors) to deliver genes to any tissue or organ in the body. 4D Molecular Therapeutics develops pipeline products which targets therapeutic areas such as retina, heart, liver, brain, skeletal muscle and lung. The company works in collaboration with other organizations such as Roche and uniQure to develop novel therapies. 4D Molecular Therapeutics is headquartered at Emeryville, California, the US.

4D Molecular Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
4D Molecular Therapeutics Raises USD3 Million in Venture Financing 10
4D Molecular Therapeutics Raises USD7 Million in Venture Financing 11
Partnerships 12
4D Molecular Therapeutics Enters into Agreement with Foundation Fighting Blindness 12
4D Molecular Therapeutics Enters into Agreement with Choroideremia Research Foundation 13
Licensing Agreements 14
uniQure Enters into Licensing Agreement with 4D Molecular Therapeutics 14
Pfizer Enters into Licensing Agreement with 4D Molecular Therapeutics 15
4D Molecular Therapeutics Enters into Licensing Agreement with Roche 16
Applied Genetic Technologies Enters into Licensing Agreement with 4D Molecular Therapeutics 17
Benitec Biopharma Enters into Licensing Agreement with 4D Molecular Therapeutics 18
4D Molecular Therapeutics Inc – Key Competitors 19
4D Molecular Therapeutics Inc – Key Employees 20
4D Molecular Therapeutics Inc – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Clinical Trials 22
Sep 19, 2017: 4D Molecular Therapeutics Receives $3 Million Follow-On Funding from Cystic Fibrosis Foundation Therapeutics for Gene Therapy IND Candidate for Cystic Fibrosis 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
4D Molecular Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
4D Molecular Therapeutics Raises USD3 Million in Venture Financing 10
4D Molecular Therapeutics Raises USD7 Million in Venture Financing 11
4D Molecular Therapeutics Enters into Agreement with Foundation Fighting Blindness 12
4D Molecular Therapeutics Enters into Agreement with Choroideremia Research Foundation 13
uniQure Enters into Licensing Agreement with 4D Molecular Therapeutics 14
Pfizer Enters into Licensing Agreement with 4D Molecular Therapeutics 15
4D Molecular Therapeutics Enters into Licensing Agreement with Roche 16
Applied Genetic Technologies Enters into Licensing Agreement with 4D Molecular Therapeutics 17
Benitec Biopharma Enters into Licensing Agreement with 4D Molecular Therapeutics 18
4D Molecular Therapeutics Inc, Key Competitors 19
4D Molecular Therapeutics Inc, Key Employees 20

★海外企業調査レポート[4D Molecular Therapeutics Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Al Arrab Contracting Company:企業の戦略的SWOT分析
    Al Arrab Contracting Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • US Foods Holding Corp (USFD):企業の財務・戦略的SWOT分析
    US Foods Holding Corp (USFD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Jacobs Engineering Group Inc.:企業の戦略・SWOT・財務情報
    Jacobs Engineering Group Inc. - Strategy, SWOT and Corporate Finance Report Summary Jacobs Engineering Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Haier Electronics Group Co Ltd:企業の戦略・SWOT・財務情報
    Haier Electronics Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Haier Electronics Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • SEAS-NVE Holding AS:企業の戦略的SWOT分析
    SEAS-NVE Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Ternium SA:戦略・SWOT・企業財務分析
    Ternium SA - Strategy, SWOT and Corporate Finance Report Summary Ternium SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • ING Groep NV:戦略・SWOT・企業財務分析
    ING Groep NV - Strategy, SWOT and Corporate Finance Report Summary ING Groep NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Apple Inc:企業の戦略・SWOT・財務分析
    Apple Inc - Strategy, SWOT and Corporate Finance Report Summary Apple Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Genedrive Plc (GDR):企業の製品パイプライン分析
    Summary Genedrive Plc (Genedrive), formerly Epistem Holdings plc, develops and markets point of need molecular diagnostics platform for identifying infectious diseases and pathogens and providing other indications. The Genedrive HCVID test is the company’s CE-IVD certified molecular diagnostics plat …
  • China National Petroleum Corp:電力:M&Aディール及び事業提携情報
    Summary China National Petroleum Corp (CNPC) is an integrated energy company. Its businesses cover oil and gas exploration and development, refining and chemicals, marketing and trading, pipeline transmission and stockpiling, technical services, engineering construction, equipment manufacturing, fin …
  • Gunvor Group Limited-石油・ガス分野:企業M&A・提携分析
    Summary Gunvor Group Limited (Gunvor) is a vertically integrated energy trading company. It is one of the global traders of physical crude oil; refined products and energy; and metals and bulk materials. The company provides integrated trading products and logistics service to connect suppliers upst …
  • E. & J. Gallo Winery:企業の戦略・SWOT・財務情報
    E. & J. Gallo Winery - Strategy, SWOT and Corporate Finance Report Summary E. & J. Gallo Winery - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • City Developments Ltd:戦略・SWOT・企業財務分析
    City Developments Ltd - Strategy, SWOT and Corporate Finance Report Summary City Developments Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Agilent Technologies Inc (A):企業の財務・戦略的SWOT分析
    Agilent Technologies Inc (A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Veloxis Pharmaceuticals AS (VELO):製薬・医療:M&Aディール及び事業提携情報
    Summary Veloxis Pharmaceuticals A/S (Veloxis) is a specialty pharmaceutical company that identifies, develops and commercializes pharmaceutical drugs in transplantation and adjacent therapies. The company developed ENVARSUS XR (tacrolimus extended-release tablets) for the prophylaxis of organ reject …
  • Polenergia SA (PEP):電力:M&Aディール及び事業提携情報
    Summary Polenergia SA (Polenergia) formerly Polish Energy Partners SA develops, implements and operates projects related to production of electricity and fuels. It offers services such as project implementation and supervision of construction, management of power facilities, production and sales of …
  • Nanomix Inc:医療機器:M&Aディール及び事業提携情報
    Summary Nanomix Inc (Nanomix) is a medical device company that develops analytical detection devices for the point of care diagnostics. The company provides Nanomix system, which is an automated system consisting of a handheld reader and self-contained assay cartridge with a carbon nanotube biosenso …
  • Premiere Global Services, Inc.:企業の戦略的SWOT分析
    Premiere Global Services, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Eastern Company SAE:企業の戦略・SWOT・財務分析
    Eastern Company SAE - Strategy, SWOT and Corporate Finance Report Summary Eastern Company SAE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Simon Property Group, Inc.:企業のM&A・事業提携・投資動向
    Simon Property Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Simon Property Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆